Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Kezar Life Sciences Shareholders Equity (Quarterly) : 65.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 65.24M |
| December 31, 2025 | 70.07M |
| September 30, 2025 | 82.98M |
| June 30, 2025 | 91.79M |
| March 31, 2025 | 103.07M |
| December 31, 2024 | 116.92M |
| September 30, 2024 | 134.05M |
| June 30, 2024 | 150.68M |
| March 31, 2024 | 169.12M |
| December 31, 2023 | 187.57M |
| September 30, 2023 | 215.99M |
| June 30, 2023 | 232.28M |
| March 31, 2023 | 252.49M |
| December 31, 2022 | 269.87M |
| September 30, 2022 | 283.19M |
| June 30, 2022 | 297.36M |
| March 31, 2022 | 232.32M |
| Date | Value |
|---|---|
| December 31, 2021 | 196.88M |
| September 30, 2021 | 119.48M |
| June 30, 2021 | 129.89M |
| March 31, 2021 | 140.64M |
| December 31, 2020 | 140.98M |
| September 30, 2020 | 150.32M |
| June 30, 2020 | 158.32M |
| March 31, 2020 | 122.65M |
| December 31, 2019 | 78.05M |
| September 30, 2019 | 86.50M |
| June 30, 2019 | 94.60M |
| March 31, 2019 | 102.14M |
| December 31, 2018 | 108.80M |
| September 30, 2018 | 114.13M |
| June 30, 2018 | 119.34M |
| March 31, 2018 | 47.44M |
| December 31, 2017 | 52.24M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| Protara Therapeutics, Inc. | 161.31M |
| Clene, Inc. | -24.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.00M |
| Total Liabilities (Quarterly) | 2.762M |
| Debt to Equity Ratio | 0.0208 |
| Current Ratio | 24.46 |
| Net Debt Paydown Yield | 5.42% |